MiRNA155HG polymorphisms influenced the risk of liver cancer among the Han Chinese population

BMC Medical Genetics

Table 2 Basic information about the candidate SNPs in this study

SNP ID	Chr.Position	Alleles	MAF		p-HWE	OR (95%CI)	p-value
SNP ID	Chr.Position	(minor/major)	Cases	Controls	p-HWE	OR (95%CI)	p-value
rs4143370	21:25564661	C/G	0.169	0.154	0.715	1.12 (0.86 - 1.44)	0.407
rs77218221	21:25565063	C/T	0.047	0.046	0.613	1.02 (0.66 - 1.60)	0.918
rs12482371	21:25566041	C/T	0.284	0.317	0.095	0.85 (0.69 - 1.05)	0.125
rs77699734	21:25566995	C/G	0.074	0.095	0.784	0.76 (0.54 - 1.07)	0.120
rs11911469	21:25567971	A/C	0.122	0.107	0.804	1.16 (0.86 - 1.56)	0.334
rs1893650	21:25568503	C/T	0.182	0.196	0.879	0.91 (0.72 - 1.16)	0.447
rs34904192	21:25569623	A/G	0.238	0.248	0.438	0.95 (0.76 - 1.18)	0.634
rs928883	21:25571713	A/G	0.494	0.454	0.624	1.18 (0.97 - 1.42)	0.099

CI confidence interval, HWE Hardy–Weinberg equilibrium, MAF minor allele frequency; p-HWE < 0.01 indicates imbalance, OR odds ratio, SNP single-nucleotide polymorphism
*p < 0.05 indicates statistical significance
*p < 0.00625 (0.05/8) indicates statistical significance for Bonferroni correction

ISSN: 1471-2350